Aemetis, Inc (NASDAQ:AMTX – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $2.02 and traded as low as $1.2550. Aemetis shares last traded at $1.27, with a volume of 1,464,838 shares.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on AMTX shares. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Thursday, October 15th. Wall Street Zen upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Saturday, August 22nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.88.
Read Our Latest Analysis on Aemetis
Aemetis Stock Up 8.3%
The company has a market cap of $93.82 million, a price-to-earnings ratio of -1.43 and a beta of 1.82. The company has a fifty day simple moving average of $1.78 and a two-hundred day simple moving average of $2.00.
Aemetis (NASDAQ:AMTX – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.16. The firm had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $67.69 million. On average, research analysts predict that Aemetis, Inc will post -0.89 EPS for the current year.
Institutional Investors Weigh In On Aemetis
Institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its position in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 8,825 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in Aemetis in the 1st quarter valued at about $33,000. Patriot Financial Group Insurance Agency LLC purchased a new stake in shares of Aemetis during the first quarter worth about $117,000. Renaissance Technologies LLC purchased a new position in Aemetis in the first quarter valued at about $272,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Aemetis in the second quarter worth $283,000. 27.02% of the stock is currently owned by hedge funds and other institutional investors.
Aemetis Company Profile
Aemetis, Inc is a renewable fuels and renewable chemicals company focused on developing and operating low-carbon production facilities. Its activities include the production of renewable natural gas, renewable fuels, ethanol, and other products designed to reduce greenhouse gas emissions from transportation and industrial operations.
The company operates an ethanol production facility in California’s Central Valley and develops dairy-based biogas and renewable natural gas projects that capture methane from agricultural waste.
Read More
- Five stocks we like better than Aemetis
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
